Endothelial dysfunction is associated with increased levels of biomarkers in essential hypertension (Q43230192)

16 November 2017

title

Endothelial dysfunction is associated with increased levels of biomarkers in essential hypertension (English)

1 reference

16 November 2017

0 references

0 references

A de la Sierra

1

1 reference

16 November 2017

M Larrousse

series ordinal

2

1 reference

16 November 2017

publication date

26 November 2009

1 reference

Journal of Human Hypertension

16 November 2017

published in

1 reference

16 November 2017

volume

24

1 reference

16 November 2017

issue

6

1 reference

16 November 2017

page(s)

373-379

1 reference

Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension.

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Endothelial dysfunction as an early sign of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

The clinical significance of endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Prognostic significance of endothelial dysfunction in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Endothelial dysfunction in salt-sensitive essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Prognostic value of coronary vascular endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Endothelial function and aminothiol biomarkers of oxidative stress in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Soluble E-selectin in essential hypertension: a correlate of vascular structural changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Circulating cell adhesion molecules and death in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Significance of Low-Dose and Standard-Dose ACTH Tests Compared to Overnight Metyrapone Test in the Diagnosis of Adrenal Insufficiency in Childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Prognostic role of flow-mediated dilatation of the brachial artery in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

The adhesion molecule P-selectin and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Soluble P-selectin and the risk of future cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Hypertension and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Does increased oxidative stress cause hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Plasma tissue inhibitor of metalloproteinase-1 levels are elevated in essential hypertension and related to left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

7 January 2021

Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

7 January 2021

Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

7 January 2021

Elevated levels of circulating cell adhesion molecules in uncomplicated essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

7 January 2021

Effects of severe, uncontrolled hypertension on endothelial activation: soluble vascular cell adhesion molecule-1, soluble intercellular adhesion molecule-1 and von Willebrand factor

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

7 January 2021

Abnormalities of the extracellular degradation of collagen type I in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

7 January 2021

Vascular cell adhesion molecule-1 as a biochemical marker of left ventricular mass in the patients with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

7 January 2021

Effect of long-term irbesartan treatment on endothelium-dependent vasodilation in essential hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

7 January 2021

Increased levels of atherosclerosis markers in salt-sensitive hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

7 January 2021

Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.91

7 January 2021

Identifiers

DOI

10.1038/JHH.2009.91

1 reference

Dimensions Publication ID

16 November 2017

1009383330

0 references

1 reference